EVO Evotec SE
$1.57▲ +3.29%
Healthcare
Other
After hours
$1.60▲ +1.91%
Oct 27, 4:49 PM ET
Volume 42.4K
Avg Volume (10D) 88.9K
Key Metrics & Fundamentals
Market Cap
$557.96M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.33 - 4.19
% vs 50 MA
-6.04%
% vs 200 MA
-38.52%
RSI-14
50.8
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.51
Free Cash Flow
-$118.20M
Gross Rev
$143.48M
Gross Profit
-$1.58M
EBITDA
-$91.03M
COGS
$145.06M
Operating Exp
$87.74M
Operating Income
-$89.32M
EBIT
-$89.32M
Pretax Income
-$48.12M
Net Income
-$46.65M
Price & Volume History
Loading chart…
Recent News
Did Evotec’s 60% Drop Catch You Out? What Investors Missed
Simply Wall St. · Oct 25, 2026 12:06 PM ET
Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board
PR Newswire · Oct 15, 2026 2:04 AM ET
Evotec shares jump after preliminary 9-month revenue, EBITDA top estimates
Investing.com · Oct 14, 2026 3:47 AM ET
4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines
GlobeNewswire · Sep 29, 2026 5:27 AM ET
Evotec Announces Chief Scientific Officer Transition
PR Newswire · Sep 29, 2026 2:04 AM ET
APTADIR RAISES A €40M ($45M) SEED FINANCING TO ADVANCE FIRST-IN-CLASS DEMETHYLATING MEDICINES
GlobeNewswire · Sep 29, 2026 12:00 AM ET
Secure the Global Drug Discovery Services Report: Capitalize on AI-driven outsourcing and benchmark Charles River, Labcorp, Evotec, WuXi AppTec and Syngene before rivals capture the next revenue wave
GlobeNewswire · Sep 24, 2026 4:02 AM ET
Capitalize on the In Vivo Toxicology Shake-Up: Benchmark Charles River, Labcorp, Evotec, WuXi AppTec and Thermo Fisher Before R&D Shifts Redraw Global Market Share
GlobeNewswire · Sep 23, 2026 4:10 AM ET
Capitalize on the Drug Discovery Outsourcing Shift: Benchmark Charles River, WuXi AppTec, Evotec, Labcorp and Sygnature to Secure R&D ROI and Outsmart the Global Market
GlobeNewswire · Sep 23, 2026 4:08 AM ET
Disrupt Drug Discovery and Secure R&D ROI: Benchmark Fragment-Based Strategies from Astex, Evotec, Charles River, Schrödinger and Vernalis Through 2030
GlobeNewswire · Sep 22, 2026 4:32 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See EVO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.